TN2015000161A1 - Methylglyoxal as a marker of cancer - Google Patents
Methylglyoxal as a marker of cancerInfo
- Publication number
- TN2015000161A1 TN2015000161A1 TNP2015000161A TN2015000161A TN2015000161A1 TN 2015000161 A1 TN2015000161 A1 TN 2015000161A1 TN P2015000161 A TNP2015000161 A TN P2015000161A TN 2015000161 A TN2015000161 A TN 2015000161A TN 2015000161 A1 TN2015000161 A1 TN 2015000161A1
- Authority
- TN
- Tunisia
- Prior art keywords
- cancer
- methylglyoxal
- early detection
- cells
- marker
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/5758—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumours, cancers or neoplasias, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides or metabolites
- G01N33/57585—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumours, cancers or neoplasias, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides or metabolites involving compounds identifiable in body fluids
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/483—Physical analysis of biological material
- G01N33/487—Physical analysis of biological material of liquid biological material
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/5758—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumours, cancers or neoplasias, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides or metabolites
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/66—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood sugars, e.g. galactose
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Molecular Biology (AREA)
- Physics & Mathematics (AREA)
- General Physics & Mathematics (AREA)
- General Health & Medical Sciences (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Pathology (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- Cell Biology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Diabetes (AREA)
- Biophysics (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/EP2012/071163 WO2014063743A1 (en) | 2012-10-25 | 2012-10-25 | Methylglyoxal as a marker of cancer |
| PCT/EP2013/072459 WO2014064283A1 (en) | 2012-10-25 | 2013-10-25 | Methylglyoxal as a marker of cancer |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| TN2015000161A1 true TN2015000161A1 (en) | 2016-10-03 |
Family
ID=47074733
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TNP2015000161A TN2015000161A1 (en) | 2012-10-25 | 2015-04-24 | Methylglyoxal as a marker of cancer |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20150301056A1 (https=) |
| JP (1) | JP6543193B2 (https=) |
| CN (1) | CN104854458B (https=) |
| CA (1) | CA2889110A1 (https=) |
| DK (1) | DK2912465T3 (https=) |
| ES (1) | ES2656896T3 (https=) |
| MA (1) | MA38042B2 (https=) |
| PT (1) | PT2912465T (https=) |
| RU (1) | RU2666255C2 (https=) |
| TN (1) | TN2015000161A1 (https=) |
| WO (2) | WO2014063743A1 (https=) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN106769349B (zh) * | 2017-01-06 | 2020-01-21 | 上海君联医疗设备有限公司 | 血液中异常糖基化蛋白细胞的检测方法 |
| CN108426996B (zh) * | 2017-02-15 | 2020-09-15 | 江苏美正生物科技有限公司 | 一种3-甲基喹噁啉-2-羧酸残留的快速检测试剂盒及其制备方法和应用 |
| GB2566681B (en) * | 2017-09-14 | 2021-07-28 | Ip2Ipo Innovations Ltd | Biomarker |
| CN108061802A (zh) * | 2017-12-08 | 2018-05-22 | 武汉科技大学 | 一种通过血液检测评定乳腺癌的方法 |
| SG11202104101TA (en) * | 2018-11-28 | 2021-05-28 | Nat Univ Singapore | Method of detecting cancer and/or tuberculosis |
| CN110604823B (zh) * | 2019-10-21 | 2020-10-20 | 兰州大学 | 一种快速筛选抗糖化和/或抗衰老物质的方法 |
| CN113376199A (zh) * | 2021-05-12 | 2021-09-10 | 兰立生物科技(苏州)有限公司 | 一种用于癌症检测的生化分析检测系统 |
| CN114496306B (zh) * | 2022-01-28 | 2022-12-20 | 北京大学口腔医学院 | 基于机器学习的预后生存阶段预测方法和系统 |
| US20220206017A1 (en) * | 2022-03-18 | 2022-06-30 | Joel Steven Goldberg | Aerobic glycolysis and hypermetabolic states |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPWO2007073005A1 (ja) * | 2005-12-22 | 2009-06-04 | 学校法人慶應義塾 | メチル基転移反応調節物質 |
| US8026049B2 (en) * | 2007-03-23 | 2011-09-27 | Wisconsin Alumni Research Foundation | Noninvasive measurement and identification of biomarkers in disease state |
| JP4836926B2 (ja) * | 2007-11-12 | 2011-12-14 | 株式会社日本トリム | 糖分解代謝物の測定方法 |
| JP5787339B2 (ja) * | 2009-12-28 | 2015-09-30 | 学校法人福岡大学 | 糖尿病前症の検査方法 |
| KR20140024860A (ko) * | 2011-02-24 | 2014-03-03 | 버밀리언, 인코포레이티드 | 난소암에 대한 바이오마커 패널，진단 방법 및 시험 키트 |
-
2012
- 2012-10-25 WO PCT/EP2012/071163 patent/WO2014063743A1/en not_active Ceased
-
2013
- 2013-10-25 JP JP2015538478A patent/JP6543193B2/ja active Active
- 2013-10-25 PT PT137830733T patent/PT2912465T/pt unknown
- 2013-10-25 WO PCT/EP2013/072459 patent/WO2014064283A1/en not_active Ceased
- 2013-10-25 DK DK13783073.3T patent/DK2912465T3/en active
- 2013-10-25 MA MA38042A patent/MA38042B2/fr unknown
- 2013-10-25 CA CA2889110A patent/CA2889110A1/en not_active Abandoned
- 2013-10-25 ES ES13783073.3T patent/ES2656896T3/es active Active
- 2013-10-25 CN CN201380063100.2A patent/CN104854458B/zh active Active
- 2013-10-25 US US14/437,911 patent/US20150301056A1/en not_active Abandoned
- 2013-10-25 RU RU2015119512A patent/RU2666255C2/ru active
-
2015
- 2015-04-24 TN TNP2015000161A patent/TN2015000161A1/fr unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CN104854458B (zh) | 2018-02-09 |
| CA2889110A1 (en) | 2014-05-01 |
| JP6543193B2 (ja) | 2019-07-10 |
| RU2666255C2 (ru) | 2018-09-06 |
| MA38042A3 (fr) | 2018-03-30 |
| CN104854458A (zh) | 2015-08-19 |
| RU2015119512A (ru) | 2016-12-20 |
| US20150301056A1 (en) | 2015-10-22 |
| MA38042B2 (fr) | 2019-11-29 |
| JP2016500821A (ja) | 2016-01-14 |
| DK2912465T3 (en) | 2018-01-15 |
| ES2656896T3 (es) | 2018-02-28 |
| MA38042A2 (fr) | 2017-02-28 |
| WO2014063743A1 (en) | 2014-05-01 |
| PT2912465T (pt) | 2018-01-25 |
| WO2014064283A1 (en) | 2014-05-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TN2015000161A1 (en) | Methylglyoxal as a marker of cancer | |
| IN2014MN02060A (https=) | ||
| WO2006091412A3 (en) | Adamts-7 as a biomarker for cancers of epithelial origin | |
| MY175351A (en) | Method and kit for measurement of nk cell activity | |
| MX343327B (es) | Ensayos para detectar autoanticuerpos contra farmacos anti-tnfa. | |
| NZ609493A (en) | Diagnosis and treatments relating to th2 inhibition | |
| WO2009090553A3 (en) | Compositions and methods of detecting post-stop peptides | |
| WO2013190075A3 (en) | Specific biomarkers for hepatocellular carcinoma (hcc) | |
| WO2009077864A3 (en) | Compositions and methods of detecting tiabs | |
| MX382244B (es) | Metodos para detectar firmas de enfermedad o condiciones en fluidos corporales | |
| WO2011145807A3 (ko) | 신경기능 검사장치 | |
| MX2013003077A (es) | Diagnostico de cancer de mama. | |
| WO2014036495A3 (en) | Diagnostic assays and kits for detection of folate receptor 1 | |
| RU2013105265A (ru) | Способ диагностики рака поджелудочной железы | |
| WO2009092386A3 (en) | A new method to measure and characterize microvesicles in the human body fluids | |
| BR112012031389A2 (pt) | método para prever os resultados clínicos para pacientes com melanoma usando células de melanoma circulantes no sangue | |
| EP2781918A4 (en) | MEANS FOR THE FAST DETECTION OF ADIPSIN FOR THE DIAGNOSIS OF PREECLAMPSIA, TESTS AND PRODUCTION METHOD THEREFOR | |
| WO2017025617A8 (en) | Method for the quantification of faecalibacterium prausnitzii phylogroup i and/or phylogroup ii members and the use thereof as biomarkers | |
| WO2014052685A3 (en) | Devices and methods for single cell analysis | |
| WO2010136163A8 (en) | Secernin-1 as a marker for cancer | |
| GB201107466D0 (en) | Device and method for non-invasive collection of colorectal mucocellular layer and disease detection | |
| JP2016500821A5 (https=) | ||
| EA201590686A1 (ru) | Тест на митохондриальную токсичность | |
| MX2012007009A (es) | Método para diagnosticar un tumor maligno. | |
| MX360479B (es) | Anticuerpos contra microbioma, factores de estres y marcadores de mastocitos como marcadores de diagnostico para ibs. |